| 产品名称: | Streptomyces avermitilis (ex Burg et al.) Kim and Goodfellow |
|---|---|
| 商品货号: | TS207217 |
| Deposited As: | Streptomyces avermitilis |
| Strain Designations: | MA 5218 |
| Application: | Produces avermectin B(1)a C-076 Produces C-076 and derivatives |
| Isolation: | Mutant derived from ATCC 3127 |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®: | no |
| Type Strain: | no |
| Medium: | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions: | Temperature: 26.0°C |
| Name of Depositor: | Merck & Co., Inc. |
| U.S. Patent Number: | |
| References: | Hafner EW, et al. Cultures for production of B avermectins. US Patent 5,565,359 dated Oct 15 1996 |